INS and type 2 diabetes mellitus: During an eight-week RCT among patients with T2D, it was observed that adding 6 mg/day nightly melatonin to the background pharmacological management of patients did not have any favorable impact on HbA1c, FBG, insulin resistance/sensitivity indices, beta cell function, and hs-CRP levels.